Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $3.02 billion. The enterprise value is $3.07 billion.
Important Dates
The last earnings date was Friday, February 28, 2025, before market open.
Earnings Date | Feb 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APLS has 125.52 million shares outstanding. The number of shares has increased by 4.40% in one year.
Current Share Class | 125.52M |
Shares Outstanding | 125.52M |
Shares Change (YoY) | +4.40% |
Shares Change (QoQ) | +0.23% |
Owned by Insiders (%) | 3.46% |
Owned by Institutions (%) | 82.64% |
Float | 84.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.82 |
Forward PS | 3.49 |
PB Ratio | 13.11 |
P/TBV Ratio | 13.21 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 2.06.
Current Ratio | 4.25 |
Quick Ratio | 3.71 |
Debt / Equity | 2.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.08 |
Financial Efficiency
Return on equity (ROE) is -93.55% and return on invested capital (ROIC) is -20.54%.
Return on Equity (ROE) | -93.55% |
Return on Assets (ROA) | -12.32% |
Return on Invested Capital (ROIC) | -20.54% |
Return on Capital Employed (ROCE) | -23.58% |
Revenue Per Employee | $1.10M |
Profits Per Employee | -$278,701 |
Employee Count | 710 |
Asset Turnover | 0.93 |
Inventory Turnover | 3.63 |
Taxes
In the past 12 months, APLS has paid $1.16 million in taxes.
Income Tax | 1.16M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.34% in the last 52 weeks. The beta is 0.92, so APLS's price volatility has been similar to the market average.
Beta (5Y) | 0.92 |
52-Week Price Change | -62.34% |
50-Day Moving Average | 29.95 |
200-Day Moving Average | 33.85 |
Relative Strength Index (RSI) | 24.72 |
Average Volume (20 Days) | 1,639,417 |
Short Selling Information
The latest short interest is 17.34 million, so 13.82% of the outstanding shares have been sold short.
Short Interest | 17.34M |
Short Previous Month | 17.06M |
Short % of Shares Out | 13.82% |
Short % of Float | 20.59% |
Short Ratio (days to cover) | 11.45 |
Income Statement
In the last 12 months, APLS had revenue of $781.37 million and -$197.88 million in losses. Loss per share was -$1.60.
Revenue | 781.37M |
Gross Profit | 336.07M |
Operating Income | -164.98M |
Pretax Income | -330.95M |
Net Income | -197.88M |
EBITDA | -163.18M |
EBIT | -164.98M |
Loss Per Share | -$1.60 |
Full Income Statement Balance Sheet
The company has $416.14 million in cash and $469.78 million in debt, giving a net cash position of -$53.65 million or -$0.43 per share.
Cash & Cash Equivalents | 416.14M |
Total Debt | 469.78M |
Net Cash | -53.65M |
Net Cash Per Share | -$0.43 |
Equity (Book Value) | 228.54M |
Book Value Per Share | 1.84 |
Working Capital | 603.45M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$87.87 million and capital expenditures -$403,000, giving a free cash flow of -$88.27 million.
Operating Cash Flow | -87.87M |
Capital Expenditures | -403,000 |
Free Cash Flow | -88.27M |
FCF Per Share | -$0.70 |
Full Cash Flow Statement Margins
Gross margin is 43.01%, with operating and profit margins of -21.11% and -25.32%.
Gross Margin | 43.01% |
Operating Margin | -21.11% |
Pretax Margin | -25.18% |
Profit Margin | -25.32% |
EBITDA Margin | -20.88% |
EBIT Margin | -21.11% |
FCF Margin | n/a |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.40% |
Shareholder Yield | -4.40% |
Earnings Yield | -6.55% |
FCF Yield | -2.92% |
Dividend Details Analyst Forecast
The average price target for APLS is $45.71, which is 89.98% higher than the current price. The consensus rating is "Buy".
Price Target | $45.71 |
Price Target Difference | 89.98% |
Analyst Consensus | Buy |
Analyst Count | 18 |
Revenue Growth Forecast (5Y) | 17.75% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of 1.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.13 |
Piotroski F-Score | 4 |